Literature DB >> 8398110

Phylogeny of the insulin-like growth factors (IGFs) and receptors: a molecular approach.

D LeRoith1, V M Kavsan, A P Koval, C T Roberts.   

Abstract

The IGFs (IGF-I and IGF-II) are essential for normal mammalian growth and development. Their actions are mediated primarily by their interactions with the type I IGF receptor (IGF-I receptor), a transmembrane tyrosine kinase. The ligands and the IGF-I receptor are structurally related to insulin and to the insulin receptor, respectively. Analysis of evolutionary conservation has often provided insights into essential regions of molecules such as hormones and their receptors. The genes for insulin and IGFs have been partially characterized in a number of vertebrate species extending evolutionarily from humans as far back as fish. The sequences of the exons encoding the mature insulin and IGF peptides are highly conserved among vertebrate species, and IGF-I-like molecules are found in species whose origins extend back as much as 550 million years. The insulin receptor is also highly conserved in vertebrate species, and an insulin-receptor-like molecule has been characterized in Drosophila. In contrast, IGF-I receptors have only been characterized in mammalian species and partially studied in Xenopus, in which the tyrosine kinase domain is highly conserved. Studies are presently being undertaken to analyze in more detail the regulation of the genes encoding this important family of growth factors and the structure/function relationships in the gene products themselves.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398110     DOI: 10.1002/mrd.1080350403

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  11 in total

1.  Growth factors regulate phototransduction in retinal rods by modulating cyclic nucleotide-gated channels through dephosphorylation of a specific tyrosine residue.

Authors:  A Savchenko; T W Kraft; E Molokanova; R H Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

3.  IGF1 stimulates differentiation of primary follicles and their growth in ovarian explants of zebrafish (Danio rerio) cultured in vitro.

Authors:  Pancharatna A Katti; Sheetal S Narvekar; Basavaraj B Goundadkar; Prasad A Deshpande
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

Review 4.  The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1).

Authors:  Andrew Wolfe; Sara Divall; Sheng Wu
Journal:  Front Neuroendocrinol       Date:  2014-06-12       Impact factor: 8.606

5.  IGF-2-like peptides are present in insulin cells of the elasmobranchian endocrine pancreas: an immunohistochemical and chromatographic study.

Authors:  M Reinecke; E Weimar; C Maake; K Drakenberg; S Falkmer; V R Sara
Journal:  Histochemistry       Date:  1994-11

Review 6.  The insulin-like growth factor system as a target in breast cancer.

Authors:  D Yee
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 7.  The IGF-II-Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives.

Authors:  Pierluigi Scalia; Antonio Giordano; Stephen J Williams
Journal:  Cancers (Basel)       Date:  2020-02-05       Impact factor: 6.639

8.  Neurotropic and modulatory effects of insulin-like growth factor II in Aplysia.

Authors:  Nikolay Vadimovich Kukushkin; Sidney Paulina Williams; Thomas James Carew
Journal:  Sci Rep       Date:  2019-10-07       Impact factor: 4.379

9.  Polymorphisms of the IGF1R gene and their genetic effects on chicken early growth and carcass traits.

Authors:  Mingming Lei; Xia Peng; Min Zhou; Chenglong Luo; Qinghua Nie; Xiquan Zhang
Journal:  BMC Genet       Date:  2008-11-07       Impact factor: 2.797

10.  Anabolic effects of IGF-1 signaling on the skeleton.

Authors:  Candice G T Tahimic; Yongmei Wang; Daniel D Bikle
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.